These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 18223510)
21. Resistance exercise training: its role in the prevention of cardiovascular disease. Braith RW; Stewart KJ Circulation; 2006 Jun; 113(22):2642-50. PubMed ID: 16754812 [No Abstract] [Full Text] [Related]
22. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589 [TBL] [Abstract][Full Text] [Related]
23. Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver. Targher G; Zoppini G; Moghetti P; Day CP Semin Thromb Hemost; 2010 Feb; 36(1):41-8. PubMed ID: 20391295 [TBL] [Abstract][Full Text] [Related]
24. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure. Onat A; Ayhan E; Hergenç G; Can G; Barlan MM Metabolism; 2009 Jul; 58(7):963-70. PubMed ID: 19411085 [TBL] [Abstract][Full Text] [Related]
25. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528 [TBL] [Abstract][Full Text] [Related]
32. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects. Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190 [TBL] [Abstract][Full Text] [Related]
33. Association between protein bound sialic acid and high sensitivity C-reactive protein in prehypertension: a possible indication of underlying cardiovascular risk. Sathiyapriya V; Selvaraj N; Nandeesha H; Bobby Z; Aparna A; Pavithran P Clin Exp Hypertens; 2008 Jul; 30(5):367-74. PubMed ID: 18633759 [TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. Karagiannides I; Abdou R; Tzortzopoulou A; Voshol PJ; Kypreos KE FEBS J; 2008 Oct; 275(19):4796-809. PubMed ID: 18754772 [TBL] [Abstract][Full Text] [Related]
35. The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis. Berneis K; Rizzo M; Spinas GA; Di Lorenzo G; Di Fede G; Pepe I; Pernice V; Rini GB Clin Chim Acta; 2009 Aug; 406(1-2):36-40. PubMed ID: 19433079 [TBL] [Abstract][Full Text] [Related]
36. Pathogenic role of abnormal fatty acids and adipokines in the portal flow. Relevance for metabolic syndrome, hepatic steatosis and steatohepatitis. Brudaşcă I; Cucuianu M Rom J Intern Med; 2007; 45(2):149-57. PubMed ID: 18333368 [TBL] [Abstract][Full Text] [Related]